ADVANTAGE INVESTMENT MANAGEMENT, LLC - SYNTA PHARMACEUTICALS CORP ownership

SYNTA PHARMACEUTICALS CORP's ticker is SNTA and the CUSIP is 87162T206. A total of 68 filers reported holding SYNTA PHARMACEUTICALS CORP in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
ADVANTAGE INVESTMENT MANAGEMENT, LLC ownership history of SYNTA PHARMACEUTICALS CORP
ValueSharesWeighting
Q2 2016$01,5000.0%0.00%
Q1 2016$0
-100.0%
1,5000.0%0.00%
-100.0%
Q4 2015$1,000
-66.7%
1,5000.0%0.00%
-50.0%
Q3 2015$3,0000.0%1,5000.0%0.00%
+100.0%
Q2 2015$3,0000.0%1,5000.0%0.00%
-50.0%
Q1 2015$3,000
-25.0%
1,5000.0%0.00%
-33.3%
Q4 2014$4,0001,5000.00%
Other shareholders
SYNTA PHARMACEUTICALS CORP shareholders Q1 2016
NameSharesValueWeighting ↓
CAXTON CORP 21,704,847$5,209,0007.19%
CAXTON CORP 67,000$16,0000.02%
McQueen, Ball & Associates Inc. 102,742$25,0000.02%
TWO SIGMA SECURITIES, LLC 36,056$9,0000.01%
JACOBS LEVY EQUITY MANAGEMENT, INC 1,398,330$336,0000.01%
WEDBUSH SECURITIES INC 45,000$11,0000.00%
Roundview Capital LLC 21,100$5,0000.00%
Renaissance Technologies 2,332,995$560,0000.00%
PANAGORA ASSET MANAGEMENT INC 618,599$148,0000.00%
Virtu KCG Holdings LLC 107,071$26,0000.00%
View complete list of SYNTA PHARMACEUTICALS CORP shareholders